Skip to main content
letter
. 2020 Apr 10;83(1):e33–e34. doi: 10.1016/j.jaad.2020.04.031

Table I.

Summary of the findings on the first randomized trial using hydroxychloroquine against COVID-1913

End points Treatment arm Control arm
Body temperature recovery time, d 2.2 3.2
Cough remission, d 2 3.1
Chest computed tomography results improvement, %, 80.6 54.8

Results are statistically significant.

Comparing results on day 0 and day 6.